Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT05512325

Not yet recruiting

Study on Gene Evolution in Glioma Under Stress Therapy

Genetic Change
NCT05469035

Not yet recruiting

The Effect of Nurse Training on the Improvement of Subcutaneous Heparin Applications

Nursing Care
NCT05382481

Recruiting

Anti Xa Monitoring Low Molecular Weight Heparin on Prevention of Venous Thromboembolism

Venous Thromboembolism
NCT05251662

Recruiting

Sintilimab Combined With GEMOX ± IBI305 (Bevacizumab Biosimilar) Versus GEMOX in Advanced Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma
NCT05041335

Not yet recruiting

Wet Heparinized Suction for Abdominal Cancer (EUS Heparin)

Cancer | Cancer of Liver | Cancer of Pancreas | Cancer of Stomach | Cancer of Esophagus
NCT04406272

Terminated

VB-111 in Surgically Accessible Recurrent/Progressive GBM

Glioblastoma | Recurrent Glioblastoma
NCT03288974

Completed

Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea (Pomalyst PMS)

Multiple Myeloma
NCT05299476

Completed

CAPOX + Bevacizumab + Tislelizumab Treating PD-L1 CPS < 5 Locally Advanced or Metastatic GEA

Advanced Gastroesophageal Adenocarcinoma | First-line Therapy | PDL1 CPS < 5
NCT01944839

Terminated

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Age-Related Macular Degeneration
NCT05275205

Completed

Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)

Neovascular Age-related Macular Degeneration
NCT03149003

Completed

A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

Glioblastoma
NCT04392479

Active, not recruiting

TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study. (TWICE-IRI)

Metastasis | Cancer Colorectal
NCT04101721

Completed

Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity (BUTTERFLEYE)

Retinopathy of Prematurity
NCT03778242

Completed

Tranexamic Acid in Pregnant Women Undergoing Cesarean Section.

Cesarean Section Complications
NCT01582776

Completed

Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell Lymphoma

Follicular Lymphoma Patients (Phase IB) | Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)
NCT04991350

Terminated

Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema (REBEL)

Diabetic Retinopathy | Diabetic Macular Edema | Vascular Endothelial Growth Factor Overexpression | Macular Ischemia
NCT05708690

Completed

Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery

Coronary Artery Disease | Valvular Heart Disease | Surgical Blood Loss
NCT01227187

Completed

Safety and Dose Finding Study of Xigris in Hemodialysis Patients (Xigris1003)

End Stage Renal Disease
NCT02590094

Completed

Preoperative Bevacizumab and Ziv-Aflibercept Administration in PDR Subjects Undergoing PPV

Diabetic Retinopathy
NCT03963466

Completed

A Clinical Observation of 1064-nm Q-Switched Fractional Laser Combined With Oral Tranexamic Acid on Treating of Melasma.

Melasma
NCT02229175

Withdrawn

Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema

Diabetic Macular Edema
NCT02718326

Completed

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR) (PANORAMA)

Nonproliferative Diabetic Retinopathy
NCT00544700

Terminated

Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

Colorectal Cancer
NCT02222714

Completed

Safety Evaluation of 3K3A-APC in Ischemic Stroke (RHAPSODY)

Ischemic Stroke
NCT00884039

Terminated

Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients

Intraocular Pressure | Transplant
NCT01708239

Unknown

Left Rule, D-Dimer Measurement and Complete Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy.

Pregnancy | Deep Vein Thrombosis
NCT03085992

Completed

Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer (TRUST)

Rectal Cancer
NCT00238238

Completed

Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab

Lymphoma
NCT00533546

Terminated

Activated Protein C in Acute Stroke Trial (APCAST)

Stroke
NCT02544724

Unknown

NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemotherapy

Lymphoma, Large B-Cell, Diffuse (DLBCL)
NCT02438566

Unknown

Non-inferiority Trial of Oral Tranexamic Acid vs. Intravenous Tranexamic Acid in Joint Replacement Surgery

Osteoarthritis | Blood Loss, Surgical | Blood Loss, Postoperative
NCT02680600

Completed

Individualized Cefepime Dosing Study (INCED)

Antimicrobial Treatment
NCT00537901

Completed

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Rectal Neoplasms | Colonic Neoplasms
NCT00577031

Completed

OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.

Colorectal Cancer
NCT02033031

Completed

Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion
NCT00462423

Completed

Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study (AbraxAvast)

Metastatic Malignant Melanoma
NCT00607113

Completed

Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma

Neuroendocrine Carcinoma
NCT01032291

Terminated

A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer

Colorectal Cancer
NCT00939510

Completed

Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer

Prostate Cancer
NCT01626339

Unknown

Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter

Age Related Macular Degeneration
NCT00081861

Completed

Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma

Lymphoma
NCT00934167

Unknown

Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patients

Venous Thromboembolism
NCT01065038

Completed

Anagrelide vs. Hydroxyurea - Efficacy and Tolerability Study in Patients With Essential Thrombocythaemia (ANAHYDRET)

Essential Thrombocythaemia
NCT00191724

Completed

Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study

Submassive Pulmonary Embolism
NCT00489710

Withdrawn

Talabostat in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer
NCT05707936

Not yet recruiting

Normal Saline Versus Heparin Intermittent Flushing for the Prevention of Occlusion in Port-a-Cath

Port-a-cath Occlusion | Normal Saline | Heparin Lock
NCT05363722

Not yet recruiting

A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT05111860

Recruiting

Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy

Rectal Cancer | Bevacizumab | Radiotherapy | Neoadjuvant Treatment
NCT01198067

Terminated

Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia

Recurrent Waldenstrom Macroglobulinemia | Refractory Waldenstrom Macroglobulinemia
NCT02604238

Withdrawn

Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism (MONALYSE)

Pulmonary Embolism

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations